226 related articles for article (PubMed ID: 24846098)
1. Imaging techniques for the evaluation of ovarian cancer.
Fischerova D; Burgetova A
Best Pract Res Clin Obstet Gynaecol; 2014 Jul; 28(5):697-720. PubMed ID: 24846098
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer.
Mironov S; Akin O; Pandit-Taskar N; Hann LE
Radiol Clin North Am; 2007 Jan; 45(1):149-66. PubMed ID: 17157627
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer: detection and radiologic staging.
Shaaban A; Rezvani M
Clin Obstet Gynecol; 2009 Mar; 52(1):73-93. PubMed ID: 19179862
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.
Nam EJ; Yun MJ; Oh YT; Kim JW; Kim JH; Kim S; Jung YW; Kim SW; Kim YT
Gynecol Oncol; 2010 Mar; 116(3):389-94. PubMed ID: 19926121
[TBL] [Abstract][Full Text] [Related]
5. Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature.
Gadducci A; Cosio S; Zola P; Landoni F; Maggino T; Sartori E
Int J Gynecol Cancer; 2007; 17(1):21-31. PubMed ID: 17291227
[TBL] [Abstract][Full Text] [Related]
6. The value of FDG-PET/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET/CT findings with conventional imaging and CA 125 as a tumour marker.
Ozcan Kara P; Kara T; Kaya B; Kara Gedik G; Sari O
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):257-60. PubMed ID: 23067527
[TBL] [Abstract][Full Text] [Related]
7. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
[TBL] [Abstract][Full Text] [Related]
8. Value of ultrasound and magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses.
Huber S; Medl M; Baumann L; Czembirek H
Anticancer Res; 2002; 22(4):2501-7. PubMed ID: 12174952
[TBL] [Abstract][Full Text] [Related]
9. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
10. [Imaging procedures in diagnosis of ovarian carcinoma].
Häusler G; Schurz B
Wien Med Wochenschr; 1996; 146(1-2):8-10. PubMed ID: 8835488
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review.
Makhija S; Howden N; Edwards R; Kelley J; Townsend DW; Meltzer CC
Gynecol Oncol; 2002 Apr; 85(1):53-8. PubMed ID: 11925120
[TBL] [Abstract][Full Text] [Related]
13. [18F-FDG PET/CT in patients, treated for ovarian cancer, with elevated CA 125 levels but no evidence of recurrence on conventional imaging].
Bochev P; Bocheva Y; Klisarova A; Ivanov S; Dancheva J; Chaushev B
Akush Ginekol (Sofiia); 2012; 51(1):18-27. PubMed ID: 22639775
[No Abstract] [Full Text] [Related]
14. Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.
Nasu K; Abe W; Takai N; Tomonari K; Narahara H
Arch Gynecol Obstet; 2011 May; 283(5):1121-6. PubMed ID: 20574659
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET/CT as a molecular biomarker in ovarian cancer.
Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
[TBL] [Abstract][Full Text] [Related]
16. [PET/CT scan with (18)F-FDG in re-staging of an atypical case of ovarian cancer].
García Gómez FJ; Cuenca Cuenca JI; Acevedo Báñez I; Borrego Dorado I; Calvo García E; Vázquez Albertino RJ
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):223-4. PubMed ID: 23067691
[No Abstract] [Full Text] [Related]
17. [The rational preoperative diagnosis of ovarian tumors - imaging techniques and tumor biomarkers (review)].
Fischerová D; Zikán M; Pinkavová I; Sláma S; Frühauf F; Freitag P; Dundr P; Burgetová A; Cibula D
Ceska Gynekol; 2012 Aug; 77(4):272-87. PubMed ID: 23094764
[TBL] [Abstract][Full Text] [Related]
18. The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging.
Manegold-Brauer G; Bellin AK; Tercanli S; Lapaire O; Heinzelmann-Schwarz V
Arch Gynecol Obstet; 2014 Mar; 289(3):491-8. PubMed ID: 24253338
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group.
Kurtz AB; Tsimikas JV; Tempany CM; Hamper UM; Arger PH; Bree RL; Wechsler RJ; Francis IR; Kuhlman JE; Siegelman ES; Mitchell DG; Silverman SG; Brown DL; Sheth S; Coleman BG; Ellis JH; Kurman RJ; Caudry DJ; McNeil BJ
Radiology; 1999 Jul; 212(1):19-27. PubMed ID: 10405715
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic imaging with positron-emission tomography in the advanced-stage ovarian cancers].
Grahek D; Hassan-Sebbag N
Bull Cancer; 2009 Dec; 96(12):1163-71. PubMed ID: 19948451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
